RIC-3 inhibitors belong to a specific chemical class that plays a pivotal role in modulating the function of RIC-3 proteins within biological systems. RIC-3, short for Resistance to Inhibitors of Cholinesterase-3, is a conserved chaperone protein that is involved in the assembly and maturation of nicotinic acetylcholine receptors (nAChRs). These receptors are integral to synaptic transmission, particularly in the neuromuscular junction, where they mediate fast signal transmission between nerve cells and muscle cells. The primary function of RIC-3 is to facilitate the proper folding and trafficking of nAChRs, ensuring their functional integration into cellular membranes. RIC-3 inhibitors, by extension, act as modulators of this intricate process.
RIC-3 inhibitors are characterized by their ability to interfere with the chaperone activity of RIC-3, disrupting the normal course of nAChR assembly. This interference may occur through various molecular mechanisms, such as binding to specific sites on RIC-3 or altering its conformation, ultimately impeding its interaction with nascent nAChRs. Consequently, the inhibition of RIC-3 by these compounds could lead to aberrant receptor folding or impaired trafficking, influencing the overall functionality of the nicotinic acetylcholine receptors. As a result, RIC-3 inhibitors hold significant promise as tools for probing the intricate regulatory mechanisms governing nAChR biogenesis, shedding light on fundamental aspects of synaptic transmission and cellular communication.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hexamethonium chloride | 60-25-3 | sc-263383 | 5 g | $32.00 | ||
A ganglionic blocker that acts as a nAChR antagonist, likely decreasing the need for RIC3's chaperone function. | ||||||
α-Bungarotoxin | 11032-79-4 | sc-202897 | 1 mg | $351.00 | 5 | |
An irreversible antagonist of nAChRs, binding prevents receptor function and may lower the chaperoning requirement of RIC3. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
An antipsychotic with known antagonist activity at nAChRs, which could decrease RIC3 chaperoning activity indirectly. | ||||||
Hemicholinium-3 | 312-45-8 | sc-252873 sc-252873A | 100 mg 500 mg | $84.00 $413.00 | ||
A choline uptake inhibitor, it decreases acetylcholine synthesis, potentially reducing nAChR turnover and RIC3 activity. | ||||||
4-Methyl-2-(1-piperidinyl)-quinoline | 5465-86-1 | sc-483337 | 25 mg | $430.00 | ||
A selective blocker of the TRPC4/5 channels, indirectly affecting calcium signaling related to nAChR function and possibly impacting RIC3. | ||||||
QX-314 | 21306-56-9 | sc-3579 sc-3579A sc-3579B sc-3579C | 100 mg 500 mg 1 g 2.5 g | $120.00 $416.00 $756.00 $1248.00 | 14 | |
A quaternary lidocaine derivative that blocks nAChRs, possibly leading to decreased RIC3 chaperoning demand. | ||||||